Lung cancer management in 2010.
Publication
, Journal Article
Ganti, AK; Huang, CH; Klein, MA; Keefe, S; Kelley, MJ
Published in: Oncology (Williston Park, N.Y.)
January 1, 2011
The introduction of newer therapies and approaches for management has led to a renewed excitement in the field of lung cancer. This trend has continued in 2010 with the adoption of the new staging system recommended by the International Association for the Study of Lung Cancer (IASLC). Novel targets, such as EML4-ALK, have been identified and agents targeting these abnormalities have shown promise in uncontrolled clinical trials, while other strategies, including combining targeted agents with cytotoxic chemotherapy in unselected patients, have not proven to be successful. This review summarizes important recent clinical advances that could have a significant impact on the future care of patients with lung cancer.
Duke Scholars
Published In
Oncology (Williston Park, N.Y.)
ISSN
0890-9091
Publication Date
January 1, 2011
Volume
25
Issue
1
Start / End Page
64 / 73
Citation
APA
Chicago
ICMJE
MLA
NLM
Ganti, A. K., Huang, C. H., Klein, M. A., Keefe, S., & Kelley, M. J. (2011). Lung cancer management in 2010. Oncology (Williston Park, N.Y.), 25(1), 64–73.
Ganti, A. K., C. H. Huang, M. A. Klein, S. Keefe, and M. J. Kelley. “Lung cancer management in 2010.” Oncology (Williston Park, N.Y.) 25, no. 1 (January 1, 2011): 64–73.
Ganti AK, Huang CH, Klein MA, Keefe S, Kelley MJ. Lung cancer management in 2010. Oncology (Williston Park, NY). 2011 Jan 1;25(1):64–73.
Ganti, A. K., et al. “Lung cancer management in 2010.” Oncology (Williston Park, N.Y.), vol. 25, no. 1, Jan. 2011, pp. 64–73.
Ganti AK, Huang CH, Klein MA, Keefe S, Kelley MJ. Lung cancer management in 2010. Oncology (Williston Park, NY). 2011 Jan 1;25(1):64–73.
Published In
Oncology (Williston Park, N.Y.)
ISSN
0890-9091
Publication Date
January 1, 2011
Volume
25
Issue
1
Start / End Page
64 / 73